MedTrace Logo

Post Market Registry Study of the AeriSeal System

NCT01520064 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2013-11-14

No results posted yet for this study

Summary

* Obtain and analyze medical record data on patients with advanced emphysema who receive treatment with the AeriSeal System to better understand safety and effectiveness in the post-market setting;
* Provide participating physicians access to specified data sets for the purpose of generating scientific manuscripts about the effects of AeriSeal System treatment.

Conditions

  • Pulmonary Emphysema

Sponsors & Collaborators

  • Aeris Therapeutics

    lead INDUSTRY

Principal Investigators

  • Janine McDermott, MS CCRP · Aeris Therapeutics

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01520064 on ClinicalTrials.gov